Navigation Links
DePuy Synthes Craniomaxillofacial Distraction System Recalled (Class I): AttorneyOne Monitors and Keeps Consumers Informed
Date:9/1/2014

San Diego, CA (PRWEB) September 01, 2014

AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on DePuy Synthes Craniomaxillofacial Distraction System.

The US FDA announced on August 28, that specific lots of DePuy Synthes Craniomaxillofacial Distraction System are recalled (Class I) as the device may reverse directions after surgery. According to the FDA, the DePuy Synthes Craniomaxillofacial (CMF) Distraction System is an implant used to lengthen and/or stabilize the lower jawbone and the side of the lower jaw in pediatric and adult patients to correct birth or post-traumatic defects of the jaw by gradually lengthening the bone.

The reason for the recall is that the device may reverse direction and lose the desired distraction distance after surgery. In the case of infant patients this may cause sudden obstruction of the trachea leading to respiratory arrest, and death.

So far there have been 15 reports of injury associated with the use of DePuy Synthes Craniomaxillofacial Distraction System. Among the general patient population, this failure may cause surgical intervention to replace the device.

The FDA classified this recall as Class I, meaning use of the products included in the recall may cause serious injuries or death.

Taking int
'/>"/>

Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related medicine news :

1. US Drug Watchdog Now Urges All Recalled DePuy ASR Hip Implant Recipients Call Them For The Names Of The Best Attorneys Out Of Fear The Recipients Will Get Nothing
2. US Drug Watchdog Now Offers To Get A Free Legal Review For All DePuy ASR Recipients Who Received A Letter From Broadspire About Their Recalled DePuy Hip Implant
3. US Drug Watchdog Now Offers To Help All Recipients Of A DePuy Pinnacle Or Recalled DePuy ASR Hip Implant Get To The Best Attorneys Regardless If Their Device Has Failed
4. US Drug Watchdog Now Urges All DePuy Pinnacle Hip Implant Recipients To Know The Symptoms Of A Failure And Offers To Name The Best Lawyers & Law Firms For Failure Victims
5. US Drug Watchdog Now Offers To Help Every Recipient Of A DePuy Pinnacle Or Recalled DePuy ASR Hip Implant Who Had To Go Through Revision Surgery Get To The Best Lawyers
6. US Drug Watchdog Dramatically Increases Their Efforts To Get All Recalled DePuy ASR Hip Implant Recipients Identified To The Best Possible Attorneys Before Time Runs Out
7. US Drug Watchdog Now Offers To Help All Recalled DePuy ASR Hip Implant Recipients Get To The Best Attorneys Out Of Fear These Recipients Won't Be Compensated
8. The US Drug Watchdog Now Offers To Help All Recipients Of Recalled DePuy ASR Hip Implant Get To The Best Attorneys Because Time Could Run Out To Get Them Identified
9. US Drug Watchdog Says Its Critical All DePuy Pinnacle Hip Implant Recipients Know The Symptoms Of A Failure And They Offer The Names Of The Best Attorneys For Victims
10. US Drug Watchdog Now Urges All DePuy Pinnacle Hip Implant Recipients To Get A Blood Test For Elevated Levels Of Cobalt Or Chromium and to Call Them If The Levels Are high
11. US Drug Watchdog Now Urges All DePuy Pinnacle And DePuy Hip Implant Recipients To Call Them For The Names Of The Best Law Firms Before Time Runs Out To Get Identified
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... ... 31, 2015 , ... “Engage: Don’t Just Age” will be ... leadership symposiums, hosted by Massachusetts-based Harmony Healthcare International at Foxwoods Resort Casino ... “C”-level executives, administrators, directors of nursing, rehabilitation managers and other management and corporate ...
(Date:7/31/2015)... ... 2015 , ... BioViva USA, Inc. (“BioViva”), a to-clinic gene therapy company based ... BioViva announces it has begun a fundraiser through Maximum Life Foundation (“MaxLife”) to use ... cure. MaxLife will grant 100% of the money raised to BioViva to help bring ...
(Date:7/31/2015)... (PRWEB) , ... July 31, 2015 , ... The alarm was ringing. Hugh Chatfield, survivor ... out of the window, he recalled that his equipment was set up to depict the ... he jumped out of bed. , The photo speaks for itself. Chatfield is also a ...
(Date:7/31/2015)... , ... July 31, 2015 , ... Awarded to only ... is proud to announce that they are the latest recipients of the Center ... status as one of the worldwide leaders in the science of hair transplant. , ...
(Date:7/31/2015)... ... 2015 , ... Eldermark Software, the innovative leader of senior ... Technologies (CAST) Medication Management Technologies whitepaper. The whitepaper is a compilation of three ... of using medication management technologies . , Eldermark’s case study ...
Breaking Medicine News(10 mins):Health News:Harmony Healthcare International Announces Speaker Line-up for “HARMONY 2015” 2Health News:Harmony Healthcare International Announces Speaker Line-up for “HARMONY 2015” 3Health News:BioViva USA, Inc.’s Alzheimer’s Disease Gene Therapy Human Trial 2Health News:BioViva USA, Inc.’s Alzheimer’s Disease Gene Therapy Human Trial 3Health News:Prestigious Medical Award Given To Parsa Mohebi Hair Restoration for Excellence in Hair Transplantation 2Health News:LeadingAge Selects Eldermark Case Study to Highlight Medication Error Reduction Results 2Health News:LeadingAge Selects Eldermark Case Study to Highlight Medication Error Reduction Results 3
... CEO: "This Deal Places IDE in a Key Position for ... Presence on the Australian ... TEL AVIV, Israel, August 12 IDE Technologies, jointly,owned ... Delek Group, signed a contract to supply a desalination plant ...
... Duska Therapeutics,Inc. (OTC Bulletin Board: DSKA) ("Duska") announced today ... Drug Administration,s (the "FDA"),Division of Cardiovascular and Renal Products ... with its lead drug, ATPace(TM), for the acute,treatment of ... On April 16, 2008, Duska met with the FDA ...
... distress to improve quality of life , , TUESDAY, ... increased risk for suicide, according to three new studies. ... of Washington analyzed U.S. data from 1973 to 2002 ... was 31.4 per 100,000 person-years, compared to 16.7 per ...
... MOUNTAIN VIEW, Calif., Aug. 12 MAP,Pharmaceuticals, Inc. (Nasdaq: ... June 30, 2008., The net loss for the second ... million during the same period in 2007. The net,loss for ... to $15.3,million for the first six months of 2007. As ...
... Texas, Aug. 12 American,HealthChoice, Inc. (Pink Sheets: ... clinics in Texas and Tennessee, is pleased to ... Scan, an infrared thermal imaging camera,that will be ... human body.,In conjunction with existing technologies, the OmniBody ...
... is celebrating the opening their latest location in Anderson ... services in the senior home care area. Preferred Care ... Alabama, Missouri and Minnesota. Of interest too, is that ... Anyone who has a desire to make a difference ...
Cached Medicine News:Health News:IDE Technologies Signs Contract Worth Over 100 Million Euros to Supply a Desalination Plant to Australia 2Health News:Duska Therapeutics Receives Comments From FDA on Phase 3 ATPace(TM) Protocol Synopsis 2Health News:Duska Therapeutics Receives Comments From FDA on Phase 3 ATPace(TM) Protocol Synopsis 3Health News:Duska Therapeutics Receives Comments From FDA on Phase 3 ATPace(TM) Protocol Synopsis 4Health News:Older Patients With Cancer at Heightened Suicide Risk 2Health News:MAP Pharmaceuticals Reports Second Quarter of 2008 Financial Results 2Health News:MAP Pharmaceuticals Reports Second Quarter of 2008 Financial Results 3Health News:MAP Pharmaceuticals Reports Second Quarter of 2008 Financial Results 4Health News:MAP Pharmaceuticals Reports Second Quarter of 2008 Financial Results 5Health News:MAP Pharmaceuticals Reports Second Quarter of 2008 Financial Results 6Health News:American HealthChoice Announces Launch of OmniBody Scan 2Health News:American HealthChoice Announces Launch of OmniBody Scan 3Health News:Senior Home care Providers keep Expanding Throughout the US 2Health News:Senior Home care Providers keep Expanding Throughout the US 3
(Date:7/31/2015)... Ill. , July 31, 2015 ... ® (NABP ® ) issued a report ... ensuring that action is taken against websites illegally ... Internet Drug Outlet Identification Program Progress Report ... , thousands of websites illegally distribute ...
(Date:7/31/2015)... 2015  Xcelience, a contract development and manufacturing ... a structured cash investment in Powdersize, a ... micronization and powder size classification within the pharmaceutical ... while simultaneously adding a complete set of particle ... "As we continue to build ...
(Date:7/31/2015)... -- Xencor, Inc. (NASDAQ: XNCR ), a clinical-stage biopharmaceutical ... autoimmune diseases, asthma and allergic diseases, and cancer, today ... to its board of directors. "Yujiro,s ... a tremendous asset to our board," said Bassil ... Xencor. "Xencor faces a range of opportunities for our ...
Breaking Medicine Technology:NABP Stresses Need for Accountability in Enforcing Internet Policies to Protect the Public From Illegal Online Drug Sellers 2NABP Stresses Need for Accountability in Enforcing Internet Policies to Protect the Public From Illegal Online Drug Sellers 3Xcelience Makes Structured Cash Investment in Powdersize 2Xcelience Makes Structured Cash Investment in Powdersize 3Xencor Appoints Yujiro S. Hata to Board of Directors 2Xencor Appoints Yujiro S. Hata to Board of Directors 3
... Conn., Oct. 6 The Hedgeye Risk Management Healthcare team, led ... Conference Call, "Aging of America: Demographics of Demand and Profits in ... long tail of demographics, why 1994-2002 was so good, and why ... device demand, and the outlook for hip, knee, and spine device ...
... Oct. 6 Roxane Laboratories, Inc. announced today ... (ANDA) for Losartan Potassium Tablets USP, 25mg, 50mg ... Hydrochlorothiazide Tablets, 50mg/12.5mg and 100mg/25mg by the U.S. ... for immediate shipment to wholesalers and pharmacies nationwide. ...
Cached Medicine Technology:Aging of America: Demographics of Demand and Profits in Healthcare 2Roxane Laboratories, Inc. Announces the Launch of Losartan Potassium Tablets USP and Losartan Potassium and Hydrochlorothiazide Tablets 2
Colloidal Gold Sol, 20 nm - 12 - 15 OD, 1 ml, Gold Sol Nanoparticles - not boiled, not centrifuged...
Colloidal Gold Sol, 20 nm - 50 OD, 1 ml, Gold Sol Nanoparticles - not boiled, not centrifuged...
CranioFix2 is the next generation CranioFix Titanium Clamp System, which is up to 40% faster than the original CranioFix and all flap fixation systems on the market....
... is an accurate, reliable, portable, and ... It works off of a dual-rechargeable ... the device a breeze. The large, ... operating and viewing results simple. Built ...
Medicine Products: